The Human Capital of Growth
By Executive Ventures & Ventures Accelerated

How the partners and people a life science company chooses early on shape how far its capital takes it
Read the full report (PDF, 2.9 MB)
This report is developed for founders, executives, board members and investors interested in understanding how the current financial climate affects how companies build, or rather assemble, the human capital required during their growth journey.
As companies bring in capital to advance their pipeline, their head count barely rises with the money raised. Instead, much of that capital will be spent through strategic partners such as CDMOs, CROs and various experts. In other words, life science companies grow by assembling capability from strategic partners bringing various sets of expertise and capabilities to the company, led by a lean execution team.
Key takeaways
- Small drug developers raise money at a steady pace of about $2–2.5M for every year they have existed, whatever their age or stage, and 84% of developers that have raised $100M or more still have 200 or fewer employees. Much of the money raised pay for work done by partners.
- Venture capital is going into fewer, larger and later rounds, so each team carries more capital and has less room to recover from an execution mistake.
- Developers that entered into a partnership with a big pharma industry partner early on, in the first five years, were 12-16 percentage points more likely to success in bringing a lead program to the clinic than companies flying solo, although they had not raised more money.
- Manufacturing or quality issues appear in three-quarters of the complete response letters the FDA has published for 2020–2024, which makes the manufacturing partner one of the most consequential choices a small company makes.
- Executives rank their people as their most valuable asset, ahead of their products.
- While a majority of founders are scientists within academia, by the time a company becomes listed, only 3% of Chief Executives have scientific background.
- Organisations that develop through partners, while having internal knowledge in that area are measurably more successful than those without internal knowledge in the partner's area.
Read the report
Download The Human Capital of Growth (PDF, 2.9 MB)
Produced by Executive Ventures in partnership with Ventures Accelerated for London Life Sciences Week, November 2026. To discuss the findings, contact Carolina Ragnerstam, CEO, at carolina@executiveventures.org.